The diagnosis of PML involves a combination of clinical performance, imaging, laboratory testing, and pathological activation. A platform can help align a team of authoritative experts at home and abroad to provide accurate diagnoses and treatments. Treatment and management of PML involves the development of personalized treatment regimens, typically including drug therapy, rehabilitation interventions, and regular follow-up to multiple-dimensional management.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved. Treatment needs to be closely monitored for effectiveness and adverse reactions, adjusted in a timely manner depending on the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML-associated pathogens.
The platform serves a team of nationally and internationally authoritative experts in the field of neural systems in China, providing the following services to patients: 1. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.